Femasys (FEMY) Income towards Parent Company (2020 - 2025)
Femasys (FEMY) posted Income towards Parent Company of -$4.6 million for Q2 2025, up 22.23% on a QoQ basis from -$5.9 million in Q1 2025, and up 2.11% year-over-year from -$4.5 million in Q2 2024.
Femasys (FEMY) Income towards Parent Company (2020 - 2025) Analysis & Trends
Femasys' Income towards Parent Company history runs 6 years deep, the most recent figure standing at -$4.6 million for Q2 2025.
- Quarterly Income towards Parent Company rose 2.11% year-over-year to -$4.6 million in Q2 2025, while the trailing twelve-month figure through Mar 2026 was -$4.6 million (up 78.28% YoY) and the FY2025 annual result came in at -$18.6 million, up 1.0% from the prior year.
- Income towards Parent Company was -$4.6 million for Q2 2025 at Femasys, up from -$5.9 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at -$1.1 million in Q2 2021 and bottomed at -$5.9 million in Q1 2025.
- A 5-year average of -$3.5 million and a median of -$3.1 million in 2022 frame the typical range for Income towards Parent Company.
- Annual changes were most pronounced in 2021 — Income towards Parent Company increased 27.09% — and 2022, when it plunged 162.38%.
- Femasys' Income towards Parent Company stood at -$2.4 million in 2021, then slipped by 27.44% to -$3.0 million in 2022, then plunged by 46.34% to -$4.4 million in 2023, then fell by 16.17% to -$5.1 million in 2024, then rose by 10.5% to -$4.6 million in 2025.
- Business Quant data shows FEMY's Income towards Parent Company at -$4.6 million in Q2 2025, -$5.9 million in Q1 2025, and -$5.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 127.02 Bn | 121.80 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.84 Bn | 44.03 Bn | 2.15 Bn |
| 3 | Alcon | 33.09 Bn | 31.43 Bn | 1.53 Bn |
| 4 | Medline | 32.94 Bn | 30.70 Bn | 1.84 Bn |
| 5 | Resmed | 29.41 Bn | 27.75 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.25 Bn | 22.82 Bn | 329.20 Mn |
| 7 | Solventum | 14.10 Bn | 13.54 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.79 Bn | 13.65 Bn | 735.40 Mn |
| 9 | Align Technology | 12.07 Bn | 11.01 Bn | 736.59 Mn |
| 10 | Femasys | 14.23 Mn | 8.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -4.59 Mn |
| Mar 31, 2025 | -5.90 Mn |
| Dec 31, 2024 | -5.12 Mn |
| Sep 30, 2024 | -5.41 Mn |
| Jun 30, 2024 | -4.68 Mn |
| Mar 31, 2024 | -3.60 Mn |
| Dec 31, 2023 | -4.41 Mn |
| Sep 30, 2023 | -4.00 Mn |
| Jun 30, 2023 | -2.89 Mn |
| Mar 31, 2023 | -3.04 Mn |
| Dec 31, 2022 | -3.01 Mn |
| Sep 30, 2022 | -3.06 Mn |
| Jun 30, 2022 | -2.84 Mn |
| Mar 31, 2022 | -2.89 Mn |
| Dec 31, 2021 | -2.36 Mn |
| Sep 30, 2021 | -2.26 Mn |
| Jun 30, 2021 | -1.08 Mn |
| Mar 31, 2021 | -1.83 Mn |
| Dec 31, 2020 | -1.66 Mn |
| Sep 30, 2020 | -1.57 Mn |